- Home
- IDCC vs HALO Comparison
IDCC vs HALO Comparison
Compare IDCC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDCC
- HALO
- Stock Information
- Founded
- IDCC 1972
- HALO 1998
- Country
- IDCC United States
- HALO United States
- Employees
- IDCC N/A
- HALO N/A
- Industry
- IDCC Multi-Sector Companies
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IDCC Miscellaneous
- HALO Health Care
- Exchange
- IDCC Nasdaq
- HALO Nasdaq
- Market Cap
- IDCC 6.9B
- HALO 7.6B
- IPO Year
- IDCC N/A
- HALO N/A
- Fundamental
- Price
- IDCC $372.01
- HALO $66.73
- Analyst Decision
- IDCC Strong Buy
- HALO Buy
- Analyst Count
- IDCC 1
- HALO 11
- Target Price
- IDCC $350.00
- HALO $73.09
- AVG Volume (30 Days)
- IDCC 432.7K
- HALO 2.2M
- Earning Date
- IDCC 10-30-2025
- HALO 11-04-2025
- Dividend Yield
- IDCC 0.65%
- HALO N/A
- EPS Growth
- IDCC 43.26
- HALO 68.93
- EPS
- IDCC 14.28
- HALO 4.37
- Revenue
- IDCC $892,584,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- IDCC N/A
- HALO $32.57
- Revenue Next Year
- IDCC N/A
- HALO $23.77
- P/E Ratio
- IDCC $25.69
- HALO $15.35
- Revenue Growth
- IDCC 21.83
- HALO 34.97
- 52 Week Low
- IDCC $144.46
- HALO $42.01
- 52 Week High
- IDCC $369.58
- HALO $79.50
- Technical
- Relative Strength Index (RSI)
- IDCC 71.97
- HALO 40.73
- Support Level
- IDCC $359.94
- HALO $63.80
- Resistance Level
- IDCC $353.61
- HALO $67.50
- Average True Range (ATR)
- IDCC 11.13
- HALO 2.31
- MACD
- IDCC -0.20
- HALO -0.34
- Stochastic Oscillator
- IDCC 85.64
- HALO 23.44
About IDCC InterDigital Inc.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.